Paper

N-methylhemeanthidine chloride, a novel Amaryllidaceae alkaloid, inhibits pancreatic cancer cell proliferation via down-regulating AKT activation.

Published Nov 1, 2014 · G. Guo, Guangmin Yao, Guanqun Zhan

Toxicology and applied pharmacology

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

N-methylhemeanthidine chloride (NMHC) shows potential as a potent chemotherapeutic agent against pancreatic cancer by inhibiting pancreatic cancer cell proliferation and apoptosis through down-regulating AKT activation.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

N-methylhemeanthidine chloride, a novel Amaryllidaceae alkaloid, inhibits pancreatic cancer cell proliferation via down-regulating AKT activation.

References

Citations